Last reviewed · How we verify
NCT03667118
Introduction and Maintenance of Still Eating Protein Blends in Support of Infant Nutritional Goals
NA trial testing Food Supplement in Food Allergy in 705 participants. Completed in 9 October 2017.
9 October 2017
Quick facts
| Lead sponsor | Northwestern University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 705 |
| Start date | 18 June 2017 |
| Primary completion | 9 October 2017 |
| Estimated completion | 9 October 2017 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Food Supplement
Conditions studied
- Food Allergy — all drugs for Food Allergy →
Sponsor
Northwestern University
Who can join
Adults 5 Months to 11 Months, any sex, with Food Allergy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to test a food supplement to: * Show that the food supplement is well tolerated and safe to feed to infants; * Find out how often parents/caregivers feed their infants the food supplement; * Find out how parents/caregivers usually add the food supplement to infants' regular solid or liquid food; and * Learn what aspects of the food supplement are more or less attractive to infants and to parents/caregivers.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
A randomized trial of the acceptability of a daily multi-allergen food supplement for infants.
Holl JL, Bilaver LA, Finn DJ, Savio K. · · 2020 · cited 12× · PMID 32030829 · DOI 10.1111/pai.13223
Verify or expand the search:
- PubMed search for NCT03667118
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Food Supplement
Trials testing the same drug.
- NCT05157425 — Effect of a Multi-strain Probiotic Formulation on Immune Response to Influenza Vaccination · NA · completed
- NCT05141903 — Dietary Supplement With and Without a Probiotic and/or Antibiotic · completed
Other recruiting trials for Food Allergy
Currently open trials in the same condition.
- NCT07210320 — PK/PD Study of IN-001 Sublingual Spray in Healthy Adults · Phase 1 · recruiting
- NCT06943534 — Omalizumab Weight-Based Dosing Efficacy Trial · Phase 2 · recruiting
- NCT06872996 — Trophallergen Prick Tests (PT) : Influence of Food Sample Shelf Life on the Reproducibility of PT Results · NA · recruiting
- NCT06529913 — Environmental Exposure to Heavy Metals, Nanoparticles, and Emergent Contaminants and Risk of Allergic Diseases · NA · recruiting
- NCT06558526 — Pectin Intervention Study and Long-term Follow-up in Lipid Transfer Proteins Allergic Patients · NA · recruiting
Other Northwestern University trials
Trials by the same sponsor.
- NCT06545695 — Epidermal Growth Factor Receptor Inhibition for Keratinopathies · Phase 1, PHASE2 · not yet recruiting
- NCT07261657 — N-803 in Patients With Progressive Synovial Sarcoma and Myxoid/Round Cell Liposarcoma Previously Treated With Adoptive C · EARLY_PHASE1 · not yet recruiting
- NCT07392775 — ALDH2 Genetic Testing in East Asian Community · NA · not yet recruiting
- NCT06886776 — Implementing A Secure Firearm Storage Program in Illinois Health Centers in Partnership With AllianceChicago and the Ill · NA · not yet recruiting
- NCT07469176 — Co-Designing and Evaluating Additional Mothers and Babies Program Content for Expectant and New Parents of Children With · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03667118 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Northwestern University
- Last refreshed: 13 March 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03667118.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing